Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.

Addresses the use of artificial intelligence by insurers and clinical peer reviewers in utilization review and establishes additional notice requirements for adverse determinations. The measure applies to health insurance utilization review processes involving AI.